BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32099592)

  • 1. Genetic heterogeneity and clonal evolution during metastasis in breast cancer patient-derived tumor xenograft models.
    Sprouffske K; Kerr G; Li C; Prahallad A; Rebmann R; Waehle V; Naumann U; Bitter H; Jensen MR; Hofmann F; Brachmann SM; Ferretti S; Kauffmann A
    Comput Struct Biotechnol J; 2020; 18():323-331. PubMed ID: 32099592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clonal evolution of metastatic colorectal cancer.
    Dang HX; Krasnick BA; White BS; Grossman JG; Strand MS; Zhang J; Cabanski CR; Miller CA; Fulton RS; Goedegebuure SP; Fronick CC; Griffith M; Larson DE; Goetz BD; Walker JR; Hawkins WG; Strasberg SM; Linehan DC; Lim KH; Lockhart AC; Mardis ER; Wilson RK; Ley TJ; Maher CA; Fields RC
    Sci Adv; 2020 Jun; 6(24):eaay9691. PubMed ID: 32577507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-Derived Xenograft Models in Breast Cancer Research.
    Na D; Moon HG
    Adv Exp Med Biol; 2021; 1187():283-301. PubMed ID: 33983584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.
    Kawaguchi T; Foster BA; Young J; Takabe K
    J Mammary Gland Biol Neoplasia; 2017 Jun; 22(2):131-139. PubMed ID: 28451789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of patient-derived xenograft mouse models for lung cancer based on exome sequencing data.
    Kim J; Rhee H; Kim J; Lee S
    Genomics Inform; 2020 Mar; 18(1):e3. PubMed ID: 32224836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
    Paez-Ribes M; Man S; Xu P; Kerbel RS
    PLoS One; 2016; 11(6):e0158034. PubMed ID: 27355476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation of breast cancer and organ microenvironment transcriptomes in metastases.
    Alzubi MA; Turner TH; Olex AL; Sohal SS; Tobin NP; Recio SG; Bergh J; Hatschek T; Parker JS; Sartorius CA; Perou CM; Dozmorov MG; Harrell JC
    Breast Cancer Res; 2019 Mar; 21(1):36. PubMed ID: 30841919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries.
    Veeranki OL; Tong Z; Mejia A; Verma A; Katkhuda R; Bassett R; Kim TB; Wang J; Lang W; Mino B; Solis L; Kingsley C; Norton W; Tailor R; Wu JY; Krishnan S; Lin SH; Blum M; Hofstetter W; Ajani J; Kopetz S; Maru D
    Dis Model Mech; 2019 Dec; 12(12):. PubMed ID: 31732509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
    Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
    Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
    [No Abstract]   [Full Text] [Related]  

  • 10. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.
    Kageyama K; Ohara M; Saito K; Ozaki S; Terai M; Mastrangelo MJ; Fortina P; Aplin AE; Sato T
    J Transl Med; 2017 Jun; 15(1):145. PubMed ID: 28645290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and metabolic comparison of orthotopic and heterotopic patient-derived pancreatic-cancer xenografts to the original patient tumors.
    Jun E; Hong SM; Yoo HJ; Kim MB; Won JS; An S; Shim IK; Chang S; Hoffman RM; Kim SC
    Oncotarget; 2018 Jan; 9(8):7867-7881. PubMed ID: 29487698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and Prospects of Patient-Derived Xenografts for Cancer Research.
    Jin J; Yoshimura K; Sewastjanow-Silva M; Song S; Ajani JA
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-derived xenografts as compatible models for precision oncology.
    Cho SY
    Lab Anim Res; 2020; 36():14. PubMed ID: 32461927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental and spontaneous metastasis assays can result in divergence in clonal architecture.
    Serrano A; Weber T; Berthelet J; El-Saafin F; Gadipally S; Charafe-Jauffret E; Ginestier C; Mariadason JM; Oakes SR; Britt K; Naik SH; Merino D
    Commun Biol; 2023 Aug; 6(1):821. PubMed ID: 37550477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Orthotopic Patient-Derived Xenograft (PDX) Model Allows the Analysis of Metastasis-Associated Features in Colorectal Cancer.
    De Angelis ML; Francescangeli F; Nicolazzo C; Xhelili E; La Torre F; Colace L; Bruselles A; Macchia D; Vitale S; Gazzaniga P; Baiocchi M; Zeuner A
    Front Oncol; 2022; 12():869485. PubMed ID: 35837106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.
    Kuukasjärvi T; Karhu R; Tanner M; Kähkönen M; Schäffer A; Nupponen N; Pennanen S; Kallioniemi A; Kallioniemi OP; Isola J
    Cancer Res; 1997 Apr; 57(8):1597-604. PubMed ID: 9108466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer.
    Echeverria GV; Powell E; Seth S; Ge Z; Carugo A; Bristow C; Peoples M; Robinson F; Qiu H; Shao J; Jeter-Jones SL; Zhang X; Ramamoorthy V; Cai S; Wu W; Draetta G; Moulder SL; Symmans WF; Chang JT; Heffernan TP; Piwnica-Worms H
    Nat Commun; 2018 Nov; 9(1):5079. PubMed ID: 30498242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.
    Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H
    Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
    Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
    J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Breast Cancer Brain Metastasis Patient-Derived Orthotopic Xenograft Model for Preclinical Studies.
    Oshi M; Okano M; Maiti A; Rashid OM; Saito K; Kono K; Matsuyama R; Endo I; Takabe K
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32074948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.